Medtronic (MDT) Net Margin (2014 - 2026)

Medtronic has disclosed Net Margin across 13 years of filings, most recently posting 12.75% for Q1 2026.

• Net Margin for Q1 2026 came in at 12.75%, down 296.0% year-over-year; the trailing twelve-month figure through Jan 2026 was 13.08% (up 17.0% YoY), and the FY2025 annual result was 13.99%, up 255.0% from the prior year.
• Net Margin came in at 12.75% for Q1 2026 at Medtronic, down from 15.42% in the prior quarter.
• In the past five years, Net Margin ranged from a high of 19.1% in Q1 2022 to a low of 5.75% in Q4 2022.
• The 5-year median for Net Margin is 13.24% (2024), against an average of 13.42%.
• Across the five-year window, Net Margin tumbled 1104 bps in 2022 and jumped 566 bps in 2023, its largest moves.
• Medtronic's Net Margin stood at 5.75% in 2022, then jumped by 99 bps to 11.41% in 2023, then jumped by 33 bps to 15.21% in 2024, then advanced by 1 bps to 15.42% in 2025, then declined by 17 bps to 12.75% in 2026.
• The last three Net Margin figures came in at 12.75% (Q1 2026), 15.42% (Q4 2025), and 12.21% (Q3 2025), per Business Quant data.